Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143


Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer.

Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, Han Y, Zhang W, Liang J, Wu K.

Int J Cancer. 2014 Nov 15;135(10):2329-37. doi: 10.1002/ijc.28883. Epub 2014 Apr 17.


MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer.

Sun L, Liu L, Liu X, Wang Y, Li M, Yao L, Yang J, Ji G, Guo C, Pan Y, Liang S, Wang B, Ding J, Zhang H, Shi Y.

Cancer Sci. 2014 Jun;105(6):651-9. doi: 10.1111/cas.12414. Epub 2014 May 12.


MGr1-Ag/37LRP promotes growth and proliferation of gastric cancer in vitro and in vivo.

Liu L, Sun L, Wu K, Shi Y, Wang Y, Wang Y, Zhang N, Zhang H, Zhang H.

Cancer Gene Ther. 2014 Sep;21(9):355-63. doi: 10.1038/cgt.2014.36. Epub 2014 Jul 25.


Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers occurs via hypoxia-inducible-factor 1-dependent mechanism and contributes to drug resistance.

Liu L, Sun L, Zhang H, Li Z, Ning X, Shi Y, Guo C, Han S, Wu K, Fan D.

Int J Cancer. 2009 Apr 1;124(7):1707-15. doi: 10.1002/ijc.24135.


Gastric cancer cell adhesion to laminin enhances acquired chemotherapeutic drug resistance mediated by MGr1-Ag/37LRP.

Sun L, Liu L, Liu X, Wang Y, Li M, Yao L, Yang J, Ji G, Guo C, Pan Y, Liang S, Wang B, Ding J, Zhang H, Shi Y.

Oncol Rep. 2014 Jul;32(1):105-14. doi: 10.3892/or.2014.3184. Epub 2014 May 15.


ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer.

Liu L, Zhang H, Sun L, Gao Y, Jin H, Liang S, Wang Y, Dong M, Shi Y, Li Z, Fan D.

Int J Cancer. 2010 Aug 15;127(4):820-9. doi: 10.1002/ijc.25098.


Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z.

World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.


MGr1-Antigen/37 kDa laminin receptor precursor promotes cellular prion protein induced multi-drug-resistance of gastric cancer.

Luo G, Wang W, Wu Q, Lu Y, Su T, Gu N, Li K, Wang J, Du R, Zhao X, Li X, Fan R, Zhang H, Nie Y, Zhou X, Shi Y, Liang J, Wang X, Fan D.

Oncotarget. 2017 May 11;8(42):71630-71641. doi: 10.18632/oncotarget.17795. eCollection 2017 Sep 22.


Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.

Sun X, Sun Z, Zhu Z, Li C, Zhang J, Xu H, Sun M.

Tumour Biol. 2015 Sep;36(10):7521-30. doi: 10.1007/s13277-015-3470-7. Epub 2015 Apr 26.


Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.

Hu X, Xin Y, Xiao Y, Zhao J.

Pathol Oncol Res. 2014 Oct;20(4):805-11. doi: 10.1007/s12253-014-9757-y. Epub 2014 Mar 19.


NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Shi R, Wang L, Wang T, Xu J, Wang F, Xu M.

Med Oncol. 2014 Mar;31(3):852. doi: 10.1007/s12032-014-0852-4. Epub 2014 Jan 28.


High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.

Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.

Ann Surg Oncol. 2010 Jan;17(1):89-97. doi: 10.1245/s10434-009-0722-z. Epub 2009 Oct 10.


Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression.

Shin E, Park DJ, Kim HH, Won NH, Choe G, Lee HS.

J Cancer Res Clin Oncol. 2013 Apr;139(4):709-18. doi: 10.1007/s00432-013-1379-3. Epub 2013 Jan 29.


Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.

Li G, Xu J, Wang Z, Yuan Y, Li Y, Cai S, He Y.

J Cancer Res Clin Oncol. 2015 Mar;141(3):443-52. doi: 10.1007/s00432-014-1838-5. Epub 2014 Sep 28.


Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.

Jin J, Jin T, Quan M, Piao Y, Lin Z.

Diagn Pathol. 2012 Oct 5;7:135. doi: 10.1186/1746-1596-7-135.


Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells.

Liu L, Ning X, Sun L, Shi Y, Han S, Guo C, Chen Y, Sun S, Yin F, Wu K, Fan D.

Mol Cell Biochem. 2007 Sep;303(1-2):151-60. Epub 2007 May 3.


Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor.

Shi Y, Zhai H, Wang X, Wu H, Ning X, Han Y, Zhang D, Xiao B, Wu K, Fan D.

Cell Mol Life Sci. 2002 Sep;59(9):1577-83.


The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.

Kanda M, Nomoto S, Oya H, Takami H, Shimizu D, Hibino S, Hashimoto R, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2016 Feb;23 Suppl 2:S214-21. doi: 10.1245/s10434-015-4457-8. Epub 2015 Mar 6.


Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.

Wang G, Gao J, Huang H, Tian Y, Xue L, Wang W, You W, Lian H, Duan X, Wu B, Wang M.

BMC Cancer. 2013 May 29;13:265. doi: 10.1186/1471-2407-13-265.


High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.

Yan P, Li YH, Tang ZJ, Shu X, Liu X.

Asian Pac J Cancer Prev. 2014;15(20):8923-9.

Supplemental Content

Support Center